{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:38:31Z","timestamp":1780396711543,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05691-5","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:43:53Z","timestamp":1769640233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In Vitro Analysis of TWEAK\/Fn14 Axis in the Blood\u2013Brain Barrier Models during Oxygen\u2013Glucose Deprivation and Reoxygenation"],"prefix":"10.1007","volume":"63","author":[{"given":"Ana","family":"Sampedro-Viana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luz","family":"Alonso-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Hervella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Burek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Iglesias-Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"5","key":"5691_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/STROKEAHA.122.036946","volume":"53","author":"E Candelario-Jalil","year":"2022","unstructured":"Candelario-Jalil E, Dijkhuizen RM, Magnus T (2022) Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities. Stroke 53(5):1473\u20131486","journal-title":"Stroke"},{"issue":"3","key":"5691_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133\u2013150","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"5691_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y (2023) The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther 8(1):217","journal-title":"Signal Transduct Target Ther"},{"key":"5691_CR4","doi-asserted-by":"crossref","unstructured":"Guttmann, C.R.G., Rousset, M., Roch, J.A., Hannoun, S., Durand-Dubief, F., Belaroussi, B., Cavallari, M., Rabilloud, M., Sappey-Marinier, D., Vukusic, S., & Cotton, F. (2016). Multiple sclerosis lesion formation and early evolution revisited: a weekly high-resolution magnetic resonance imaging study. Mult Scler. 2016;22(6):761-","DOI":"10.1177\/1352458515600247"},{"issue":"14","key":"5691_CR5","doi-asserted-by":"publisher","first-page":"1248970","DOI":"10.3389\/fneur.2023.1248970","volume":"2023","author":"S Xue","year":"2023","unstructured":"Xue S, Zhou X, Yang ZH, Si XK, Sun X (2023) Stroke-induced damage on the blood\u2013brain barrier. Front Neurol 2023(14):1248970","journal-title":"Front Neurol"},{"issue":"1","key":"5691_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2019) Blood-brain barrier: from physiology to disease and back. Physiol Rev 99(1):21\u201378","journal-title":"Physiol Rev"},{"issue":"38","key":"5691_CR7","doi-asserted-by":"publisher","first-page":"8237","DOI":"10.1523\/JNEUROSCI.1089-04.2004","volume":"24","author":"I Potrovita","year":"2004","unstructured":"Potrovita I, Zhang W, Burkly L, Hahm K, Lincecum J, Wang MZ, Maurer MH, Rossner M, et al. (2004) Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration. J Neurosci 24(38):8237\u20138244","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"5691_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0165-5728(02)00368-5","volume":"133","author":"S Desplat-J\u00e9go","year":"2002","unstructured":"Desplat-J\u00e9go S, Varriale S, Creidy R, Terra R, Bernard D, Khrestchatisky M, Izui S, Chicheportiche Y, et al. (2002) TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity. J Neuroimmunol 133(1\u20132):116\u2013123","journal-title":"J Neuroimmunol"},{"key":"5691_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-10-9","volume":"10","author":"D Stephan","year":"2013","unstructured":"Stephan D, Sbai O, Wen J, Couraud P-O, Putterman Ch, Khrestchatisky M, Desplat-J\u00e9go S (2013) TWEAK\/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier. J Neuroinflammation 10:9","journal-title":"J Neuroinflammation"},{"issue":"2","key":"5691_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/acn3.51502","volume":"9","author":"A da Silva-Candal","year":"2022","unstructured":"da Silva-Candal A, Custodia A, L\u00f3pez-Dequidt I, Rodr\u00edguez-Y\u00e1\u00f1ez M, Alonso-Alonso ML, \u00c1vila-G\u00f3mez P et al (2022) sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy. Ann Clin Transl Neurol 9(2):171\u2013180","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"5691_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11154-021-09688-4","volume":"23","author":"W Ratajczak","year":"2022","unstructured":"Ratajczak W, Atkinson SD, Kelly C (2022) The TWEAK\/Fn14\/CD163 axis-implications for metabolic disease. Rev Endocr Metab Disord 23(3):449\u2013462","journal-title":"Rev Endocr Metab Disord"},{"issue":"8","key":"5691_CR12","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1681\/ASN.2020071094","volume":"32","author":"A Cordido","year":"2021","unstructured":"Cordido A, Nu\u00f1ez-Gonzalez L, Martinez-Moreno JM, Lamas-Gonzalez O, Rodriguez-Osorio L, Perez-Gomez MV et al (2021) TWEAK signaling pathway blockade slows cyst growth and disease progression in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 32(8):1913\u20131932","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"5691_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.220","volume":"7","author":"L H\u00e9naut","year":"2016","unstructured":"H\u00e9naut L, Sanz AB, Martin-Sanchez D, Carrasco S, Villa-Bellosta R, Aldamiz-Echevarria G et al (2016) TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NF\u03baB. Cell Death Dis 7(7):e2305","journal-title":"Cell Death Dis"},{"issue":"2","key":"5691_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020405","volume":"9","author":"N M\u00e9ndez-Barbero","year":"2020","unstructured":"M\u00e9ndez-Barbero N, Guti\u00e9rrez-Mu\u00f1oz C, Bl\u00e1zquez-Serra R, Mart\u00edn-Ventura JL, Blanco-Colio LM (2020) Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)\/fibroblast growth factor-inducible 14 (Fn14) axis in cardiovascular diseases: progress and challenges. Cells 9(2):405","journal-title":"Cells"},{"issue":"12","key":"5691_CR15","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.4049\/jimmunol.178.12.8183","volume":"178","author":"LC Bover","year":"2007","unstructured":"Bover LC, Card\u00f3-Vila M, Kuniyasu A, Sun J, Rangel R, Takeya M et al (2007) A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J Immunol 178(12):8183\u20138194","journal-title":"J Immunol"},{"key":"5691_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cca.2019.04.070","volume":"495","author":"B Tang","year":"2019","unstructured":"Tang B, Zhong Z, Qiu Z, Wu HP, Hu JY, Ma JP et al (2019) Serum soluble TWEAK levels in severe traumatic brain injury and its prognostic significance. Clin Chim Acta 495:227\u2013232","journal-title":"Clin Chim Acta"},{"key":"5691_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/131950","volume":"2014","author":"KU Jarr","year":"2014","unstructured":"Jarr KU, Eschricht S, Burkly LC, Preusch M, Katus HA, Frey N et al (2014) Tnf-like weak inducer of apoptosis aggravates left ventricular dysfunction after myocardial infarction in mice. Mediators Inflamm 2014:2014:131950","journal-title":"Mediators Inflamm"},{"key":"5691_CR18","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.jaci.2020.12.657","volume":"147","author":"A Srivastava","year":"2021","unstructured":"Srivastava A, Luo L, Lohcharoenkal W, Meisgen F, Pasquali L, Pivarcsi A et al (2021) Cross-talk between IFN-\u03b3 and TWEAK through miR-149 amplifies skin inflammation in psoriasis. J Allergy Clin Immunol 147:2225\u20132235","journal-title":"J Allergy Clin Immunol"},{"issue":"177","key":"5691_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.24976\/Discov.Med.202335177.51","volume":"35","author":"H Zhang","year":"2023","unstructured":"Zhang H, Ran WR (2023) TWEAK knockdown alleviates post-cardiac arrest brain injury via the p38 MAPK\/NF-\u03baB Pathway. Discov Med 35(177):503\u2013516","journal-title":"Discov Med"},{"issue":"1\u20132","key":"5691_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jns.2008.08.005","volume":"275","author":"I Inta","year":"2008","unstructured":"Inta I, Frauenknecht K, D\u00f6rr H, Kohlhof P, Rabsilber T, Auffarth GU, Burkly L, Mittelbronn M, et al. (2008) Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke. J Neurol Sci 275(1\u20132):117\u2013120","journal-title":"J Neurol Sci"},{"key":"5691_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/17562864241243274","volume":"17","author":"P Hervella","year":"2024","unstructured":"Hervella P, Alonso-Alonso ML, Sampedro-Viana A, Rodr\u00edguez-Y\u00e1\u00f1ez M, L\u00f3pez-Dequidt I, Pumar JM et al (2024) Differential blood-based biomarkers of subcortical and deep brain small vessel disease. Ther Adv Neurol Disord 17:17562864241243274","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"5691_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/svn-2020-000684","volume":"6","author":"A da Silva-Candal","year":"2021","unstructured":"da Silva-Candal A, L\u00f3pez-Dequidt I, Rodriguez-Ya\u00f1ez M, \u00c1vila-G\u00f3mez P, Pumar JM, Jos\u00e9 CJ et al (2021) sTWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage. Stroke Vasc Neurol 6(4):528\u2013535","journal-title":"Stroke Vasc Neurol"},{"issue":"2","key":"5691_CR23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0002-9440(10)62273-0","volume":"166","author":"M Yepes","year":"2005","unstructured":"Yepes M, Brown SAN, Moore EG, Smith EP, Lawrence DA, Winkles JA (2005) A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. Am J Pathol 166(2):511\u2013520","journal-title":"Am J Pathol"},{"key":"5691_CR24","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.2741\/2271","volume":"12","author":"M Yepes","year":"2007","unstructured":"Yepes M (2007) Tweak and FN14 in central nervous system health and disease. Front Biosci 12:2772\u20132781","journal-title":"Front Biosci"},{"key":"5691_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-45","volume":"9","author":"R Echeverry","year":"2012","unstructured":"Echeverry R, Wu F, Haile WB, Wu J, Yepes M (2012) The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system. J Neuroinflammation 9:45","journal-title":"J Neuroinflammation"},{"key":"5691_CR26","doi-asserted-by":"publisher","first-page":"10094","DOI":"10.1523\/JNEUROSCI.3382-05.2005","volume":"25","author":"R Polavarapu","year":"2005","unstructured":"Polavarapu R, Gongora MC, Winkles JA, Yepes M (2005) Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. J Neurosci 25:10094\u201310100","journal-title":"J Neurosci"},{"key":"5691_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8792","volume":"6","author":"H Akahori","year":"2015","unstructured":"Akahori H, Karmali V, Polavarapu R, Lyle AN, Weiss D, Shin E et al (2015) CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury. Nat Commun 6:7792","journal-title":"Nat Commun"},{"key":"5691_CR28","doi-asserted-by":"crossref","unstructured":"Zhang X., Winkles J.A., Gongora M.C., Polavarapu R., Michaelson J.S., Hahm K., et la. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia. J. Cereb Blood Flow Metab. 2007, 27, 534\u2013544.","DOI":"10.1038\/sj.jcbfm.9600368"},{"issue":"1","key":"5691_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.clim.2005.06.005","volume":"117","author":"S Desplat-J\u00e9go","year":"2005","unstructured":"Desplat-J\u00e9go S, Simone Varriale RC, Allaire N, Luo Y, Bernard D, Hahm K, Burkly L, Boucraut J (2005) Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis. Clin Immunol 117(1):15\u201323","journal-title":"Clin Immunol"},{"key":"5691_CR30","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.neuroscience.2010.10.029","volume":"171","author":"WB Haile","year":"2010","unstructured":"Haile WB, Echeverry R, Wu F, Guzman J, An J, Wu J, Yepes M (2010) Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death. Neuroscience 171:1256\u20131264","journal-title":"Neuroscience"},{"key":"5691_CR31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s12975-018-0683-2","volume":"10","author":"M Burek","year":"2019","unstructured":"Burek M, Konig A, Lang M, Fiedler J, Oerter S, Roewer N, Bohnert M, Thal SC, et al. (2019) Hypoxia-induced microRNA-212\/132 alter blood-brain barrier integrity through inhibition of tight junction-associated proteins in human and mouse brain microvascular endothelial cells. Transl Stroke Res 10:672\u2013683","journal-title":"Transl Stroke Res"},{"key":"5691_CR32","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1177\/0271678X16630991","volume":"36","author":"HC Helms","year":"2016","unstructured":"Helms HC, Abbott NJ, Burek M, Cecchelli R, Couraud PO, Deli MA, Forster C, Galla HJ et al (2016) In vitro models of the blood-brain barrier: an overview of commonly used brain endothelial cell culture models and guidelines for their use. J Cereb Blood Flow Metab 36:862\u2013890","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"5691_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12987-020-00179-3","volume":"17","author":"A Gerhartl","year":"2020","unstructured":"Gerhartl A, Pracser N, Vladetic A, Hendrikx S, Friedl H-P, Neuhaus W (2020) The pivotal role of micro-environmental cells in a human blood\u2013brain barrier in vitro model of cerebral ischemia: functional and transcriptomic analysis. Fluids Barriers CNS 17(1):19","journal-title":"Fluids Barriers CNS"},{"issue":"9","key":"5691_CR34","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/jps.24329","volume":"104","author":"A Wolff","year":"2015","unstructured":"Wolff A, Antfolk M, Brodin B, Tenje M (2015) In vitro blood-brain barrier models-an overview of established models and new microfluidic approaches. J Pharm Sci 104(9):2727\u20132746","journal-title":"J Pharm Sci"},{"issue":"4","key":"5691_CR35","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s12035-022-02745-2","volume":"59","author":"M Babu","year":"2022","unstructured":"Babu M, Singh N, Datta A (2022) In vitro oxygen glucose deprivation model of ischemic stroke: a proteomics-driven systems biological perspective. Mol Neurobiol 59(4):2363\u20132377","journal-title":"Mol Neurobiol"},{"issue":"19","key":"5691_CR36","doi-asserted-by":"publisher","first-page":"12976","DOI":"10.1074\/jbc.M114.563478","volume":"289","author":"S Gurunathan","year":"2014","unstructured":"Gurunathan S, Winkles AJ, Ghosh S, Hayden MS (2014) Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation. J Biol Chem 289(19):12976\u201312988","journal-title":"J Biol Chem"},{"issue":"1","key":"5691_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-021-00291-y","volume":"18","author":"RM Linville","year":"2021","unstructured":"Linville RM, Peter C, Searson PC (2021) Next-generation in vitro blood\u2013brain barrier models: benchmarking and improving model accuracy. Fluids barriers CNS 18(1):56","journal-title":"Fluids barriers CNS"},{"issue":"2","key":"5691_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1189\/jlb.0112042","volume":"92","author":"T Dohi","year":"2012","unstructured":"Dohi T, Burkly LC (2012) The TWEAK\/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases: biomarkers and therapeutic strategies. J Leukoc Biol 92(2):265\u2013279","journal-title":"J Leukoc Biol"},{"key":"5691_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00367","volume":"4","author":"M Yepes","year":"2013","unstructured":"Yepes M (2013) TWEAK and Fn14 in the neurovascular unit. Front Immunol 4:367","journal-title":"Front Immunol"},{"issue":"1","key":"5691_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12987-020-00192-6","volume":"17","author":"CJ Curtaz","year":"2020","unstructured":"Curtaz CJ, Schmitt C, Herbert SL, Feldheim J, Schlegel N, Gosselet F, Hagemann C, Roewer N et al (2020) Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model. Fluids Barriers CNS 17(1):31","journal-title":"Fluids Barriers CNS"},{"key":"5691_CR41","doi-asserted-by":"publisher","unstructured":"Urich E, Lazic SE, Molnos J, Wells I, Freskg\u00e5rd P-O (2012) Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models. PLoS ONE 7(5):e38149. https:\/\/doi.org\/10.1371\/journal.pone.0038149","DOI":"10.1371\/journal.pone.0038149"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05691-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05691-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:43:55Z","timestamp":1769640235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05691-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5691"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05691-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"402"}}